Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies

Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies have?

Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies has 274 citations in the OpenAlex counts ScholarIQ stores.

When was Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies published?

Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies has 2017 year in the ScholarIQ index.

What is the open-access status of Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?

Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies has bronze oa status in the ScholarIQ index.

What is the DOI of Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?

The DOI for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is on the source record.

What is the PMID of Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?

The PMID for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is on the source record.

What is the OpenAlex record for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies?

The OpenAlex for Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies is on the source record.